Blog

Shoe Zone (LSE:SHOE) reported a difficult first half, with revenue declining 12% to £62.9 million as weaker consumer confidence, store closures, and softer online demand weighed on performance. The retailer moved to a pre-tax loss of £5.3 million during the period, prompting management to lower its full-year outlook and suspend the interim dividend.

In response to the weaker trading environment, the company is accelerating its transition toward larger-format stores while tightening capital expenditure and reducing the footprint of its distribution operations. Despite the challenging conditions, Shoe Zone ended the period with a net cash position of £7.5 million, maintaining financial flexibility amid ongoing macroeconomic and geopolitical uncertainty.

Operationally, the group closed 14 stores and opened four larger-format locations, increasing the number of refitted stores within its estate to 206. The company has also reduced average lease durations to 2.3 years in an effort to preserve operational flexibility.

Alongside store portfolio changes, Shoe Zone continues to invest in digital initiatives, including the rollout of a new mobile app and expansion through TikTok Shop. Management cautioned, however, that higher transport costs, weaker sterling, and elevated fuel prices are expected to place further pressure on margins, despite improvements in product margins and lower inventory levels aimed at matching softer customer demand.

The company’s outlook remains constrained by deteriorating profitability and a strongly bearish technical picture, with the shares trading below key moving averages and showing negative MACD momentum. These pressures are partly balanced by comparatively stable cash generation and a moderate valuation based on earnings metrics.

More About Shoe Zone

Shoe Zone PLC is a UK footwear retailer operating a nationwide chain of value-focused stores alongside an expanding digital business. The company sells affordable footwear through 259 retail outlets, with an increasing emphasis on larger-format stores, while also growing its online presence through proprietary e-commerce platforms and third-party marketplace partnerships targeting price-conscious consumers.

CelLBxHealth (LSE:CLBX) has implemented a significant organisational restructuring during the first quarter of 2026 as part of its updated strategic plan, reducing headcount to 39 employees and achieving more than £6.6 million in annualised cash operating cost savings. Management indicated that additional cost reductions are expected during the second quarter as the company continues efforts to streamline operations while retaining the capability needed to meet key commercial objectives.

The company reported cash reserves of £4.3 million at the end of March, reflecting the impact of restructuring-related expenses. Alongside the cost-cutting measures, CelLBxHealth is intensifying its commercial expansion strategy, including the appointment of a new head of U.S. sales.

Management is targeting revenue of at least £2.1 million for 2026, representing projected growth of approximately 50% compared with the previous year. The company also disclosed that it is engaged in advanced discussions with a major private U.S. healthcare provider regarding two clinical studies and is nearing a master services agreement with a top ten global pharmaceutical company involving use of its Parsortix platform.

CelLBxHealth said these potential agreements could represent transformational commercial opportunities, with the potential to further increase revenue expectations and strengthen the company’s position within oncology diagnostics and drug development markets.

The company’s outlook remains affected by substantial financial challenges and bearish technical indicators, which continue to weigh heavily on sentiment. While recent corporate developments and operational progress provide some positive momentum, concerns surrounding financial performance and valuation continue to dominate the broader investment case.

More About CelLBxHealth plc

CelLBxHealth plc is a circulating tumour cell (CTC) intelligence company focused on developing technologies for cancer research, drug development, and clinical oncology applications. Its proprietary Parsortix platform is designed to isolate circulating tumour cells from blood samples for downstream imaging, proteomic, and genomic analysis. The company generates revenue through product sales, laboratory services, and lab-developed testing solutions delivered via CROs, clinical laboratories, and strategic partnerships.

Rockfire Resources (LSE:ROCK) has provided an update on drilling activity at its wholly owned Molaoi zinc project in Greece, where the company is working to upgrade the deposit’s resource classification from Inferred to Indicated status. The latest drill hole, HMO-016, intersected several narrow but high-grade zones containing zinc, lead, and silver mineralisation at depth.

According to management, portable XRF readings from the latest drilling included one of the strongest zinc grades recorded at the project to date. The new results also indicate that the main mineralised structure may steepen significantly at depth, potentially transitioning into a near-vertical feeder zone associated with higher-grade mineralisation.

Rockfire said this interpretation could have important implications for future underground mining, as a steeper geometry may allow for simpler, safer, and more cost-effective extraction methods. To accelerate exploration progress, the company has also ordered its own drilling rig, reinforcing its commitment to advancing Molaoi as a strategically important base metals and critical minerals project.

The company’s outlook remains weighed down by weak financial performance, including the absence of revenue, continuing losses, and negative free cash flow. These pressures are partly offset by Rockfire’s debt-free balance sheet and signs of improving operating cash flow. Technical indicators remain supportive and contribute positively to sentiment, while valuation metrics continue to be constrained by a negative price-to-earnings ratio and the lack of dividend information.

More About Rockfire Resources PLC

Rockfire Resources is a London-listed exploration company focused on gold, base metals, and critical minerals. Its flagship asset is the high-grade zinc, lead, silver, and germanium deposit at Molaoi in Greece. The company also holds a portfolio of gold, copper, and silver projects in Queensland, Australia, including the Plateau deposit and the historic Marengo goldfield, both of which are subject to farm-in agreements with ASX-listed partners.

Victrex (LSE:VCT) reported a modest 1% increase in interim revenue to £147.1 million, supported by a 6% rise in sales volumes. However, underlying pre-tax profit declined 18% to £19 million as margins came under pressure from a weaker product mix, competitive pricing conditions, and adverse currency movements. Medical segment revenue also fell 9%, impacted by the timing of customer orders and pricing pressures.

The company posted a reported pre-tax loss of £44 million following a £60.6 million non-cash impairment charge linked to its manufacturing facility in China. Despite the weaker profitability, Victrex maintained its interim dividend at the previous level, while net debt increased slightly during the period. Management noted stronger trading conditions in the second quarter alongside resilient demand across sustainable solutions and industrial end markets.

Chief executive James Routh said the company’s profit improvement programme is progressing, including plans for an approximate 10% reduction in central function headcount, portfolio simplification measures, and the implementation of a revised operating model. Victrex expects these initiatives to generate at least £10 million in annual cost savings by FY2027, with some benefits anticipated from late 2026 onward.

The company also confirmed plans for a capital markets day in September, where management intends to present an updated strategy and refreshed leadership structure. Victrex continues to guide for full-year underlying pre-tax profit in the range of £42 million to £44 million as it works to improve profitability and strengthen execution within an increasingly competitive PEEK materials market.

Victrex’s broader outlook remains supported by a relatively stable balance sheet, characterised by strong equity levels and low leverage. Technical indicators currently suggest positive short-term momentum, while valuation metrics are aided by a comparatively high dividend yield. However, softer revenue growth, weaker profitability trends, and concerns raised during recent earnings discussions continue to weigh on sentiment.

More About Victrex

Victrex is a UK-based specialist in high-performance polymer solutions, with a focus on PEEK and PAEK materials used across industries including automotive, aerospace, electronics, energy, industrial manufacturing, and medical devices. Its advanced polymer technologies are incorporated into products ranging from smartphones and vehicles to aircraft components and medical implants, supporting a diversified and innovation-driven industrial portfolio.

Renew Holdings’ (LSE:RNWH) subsidiary Excalon Limited has acquired PWR-X Ltd, a specialist cable jointing contractor serving the power sector, for £1.1 million on a cash- and debt-free basis. The acquisition was initially financed through £0.75 million drawn from existing banking facilities and is intended to enhance Excalon’s technical capabilities within the high-voltage electricity market.

The addition of PWR-X is expected to strengthen Renew’s service offering across the UK power infrastructure sector by adding specialist expertise in cable jointing and related services. The company said the deal aligns with its broader strategy of expanding its presence in regulated and non-discretionary infrastructure markets, where long-term investment demand remains supported.

Renew also indicated that it continues to evaluate a wider pipeline of acquisition opportunities, reinforcing its consolidation-led growth strategy within the critical infrastructure engineering services sector.

The company’s outlook remains supported by strong financial performance, including consistent revenue growth and disciplined cash management, which continue to underpin investor confidence. While technical indicators suggest some short-term share price weakness, there remains potential for recovery momentum. Valuation metrics appear broadly reasonable, with the stock viewed as fairly valued and supported by a moderate dividend yield. The lack of recent earnings call or major corporate event data had little effect on the overall assessment.

More About Renew Holdings plc

Renew Holdings plc is a UK engineering services group focused on maintaining and renewing essential national infrastructure. Operating through a portfolio of independently branded subsidiaries, the company provides maintenance and renewal services across regulated sectors including rail, infrastructure, energy, environmental services, wind power, and nuclear. Its business model is supported by long-term funding visibility tied to non-discretionary infrastructure spending.

Kendrick Resources (LSE:KEN) has announced a significant development at its Teufelskuppe rare earth project in southwest Namibia, where updated volumetric modelling and a high-resolution digital elevation survey have outlined approximately 14 million tonnes of high-grade, near-surface carbonatite mineralisation.

According to the company’s internal non-JORC estimate, supported by bulk density measurements, the exposed mineralisation carries total rare earth oxide (TREO) grades ranging from 2.2% to 7.06%. Kendrick said the results position Teufelskuppe among the highest-grade rare earth projects globally, with the added advantage of clearly visible and easily accessible mineralisation that could reduce geological and development risk.

Management noted that the current estimate relates only to the exposed surface component of the mineralised system. Previous drilling has already confirmed significant mineralisation extending at depth, indicating potential for further resource expansion. The company also highlighted nearby Kieshöhe as a prospective area that may host even larger open-pittable mineralised volumes.

Kendrick is continuing diamond drilling and channel sampling programmes at Teufelskuppe with the aim of converting both surface and subsurface mineralisation into a JORC-compliant resource estimate. The company believes ongoing exploration success could strengthen its position within the global rare earths market.

Kendrick’s overall outlook continues to be constrained by weak financial fundamentals, including the absence of revenue, recurring losses, negative cash flow, and a significantly weakened 2025 balance sheet marked by negative equity and a sharp reduction in assets. While technical indicators remain comparatively positive, with the shares trading above major moving averages and maintaining supportive momentum, these factors are outweighed by the financial and valuation risks associated with the company’s ongoing losses and negative price-to-earnings ratio.

More About Kendrick Resources PLC

Kendrick Resources Plc is a mineral exploration and development company focused on advancing resource projects primarily across southern Africa. The company is currently developing the Bonya rare earth project in Namibia alongside the Blue Fox licence in northwest Zambia, with a strategy centred on progressing assets toward production or value-generating transactions.

Compass Group (LSE:CPG) delivered strong first-half results for 2026, with revenue increasing 9% on a constant-currency basis to $25 billion and underlying operating profit rising 12%. The company’s underlying operating margin improved to 7.4%, supported by solid organic growth and continued operational efficiencies.

Organic revenue advanced 7.2%, driven by a client retention rate of 96% and $4.1 billion in new business wins, around half of which came from first-time outsourcing contracts. Underlying earnings per share also rose 12%, while free cash flow reached $825 million, enabling the company to raise its interim dividend by 13%.

Compass is continuing to invest heavily in expansion initiatives aimed at strengthening its competitive position. During the period, the group completed $2.3 billion in acquisitions and invested a further $0.8 billion in capital expenditure. Recent deals included the integration of Dutch premium food operator Vermaat and the acquisition of German procurement specialist Pro Care Management, moves designed to expand Compass’s presence and capabilities across Europe.

Following the strong first-half performance, management upgraded its guidance for 2026 and now expects underlying operating profit growth of more than 11%. The forecast is based on approximately 7% organic revenue growth, an additional 2% contribution from acquisitions, and ongoing margin expansion. The company said the updated outlook reflects confidence that profit growth will continue to outpace revenue growth over the medium term, despite leverage temporarily increasing to 1.7 times EBITDA.

Compass’s outlook remains supported by robust financial performance and positive management commentary highlighting strong profit momentum and operational discipline. However, technical indicators currently point to weaker share price momentum, while valuation metrics suggest the stock trades at a relatively elevated level. Investors are also weighing the company’s conservative long-term growth assumptions and the short-term increase in leverage.

More About Compass

Compass Group PLC is a global provider of outsourced food services and support solutions, serving sectors including business and industry, healthcare, education, and leisure. The company operates through a decentralised and sector-focused business model, supported by significant purchasing scale and increasing use of data, technology, and artificial intelligence. Compass is targeting long-term structural growth in the global food services industry, which it expects to expand substantially over the coming decade.